Stcube Inc
052020
Company Profile
Business description
Stcube Inc is a biopharmaceutical company, develops therapies to treat novel immune evasion mechanisms in cancer in Korea.
Contact
No.2201, Korea World Trade Center Trade Tower
511, Yeongdong-daero
Samsung-dong
Gangnam-gu
Seoul06164
KORT: +82 25513370
Sector
Technology
Stock type
Sensitive
Industry
Electronics & Computer Distribution
Fiscal Year End
31 December 2025
Employees
17
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,526.90 | 320.70 | -4.09% |
| CAC 40 | 7,274.95 | 324.03 | -4.26% |
| DAX 40 | 20,641.72 | 1,075.67 | -4.95% |
| Dow JONES (US) | 38,314.86 | 2,231.07 | -5.50% |
| FTSE 100 | 8,054.98 | 419.76 | -4.95% |
| HKSE | 20,009.55 | 2,840.26 | -12.43% |
| NASDAQ | 15,587.79 | 962.82 | -5.82% |
| Nikkei 225 | 31,588.79 | 2,191.79 | -6.49% |
| NZX 50 Index | 11,775.88 | 449.40 | -3.68% |
| S&P 500 | 5,074.08 | 322.44 | -5.97% |
| S&P/ASX 200 | 7,347.40 | 320.40 | -4.18% |
| SSE Composite Index | 3,076.80 | 265.21 | -7.94% |